Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01484730 · ClinicalTrials.gov registry record

A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

A clinical trial of Abnormal Vascular Flow, sponsored by University of California, Irvine.

Recruiting
Registry status
150
Enrollment target
1
Study location

NCT01484730: Recruiting study of Abnormal Vascular Flow, sponsored by University of California, Irvine.

NCT01484730 is a study of Abnormal Vascular Flow that is actively recruiting participants, run by University of California, Irvine. The registered enrollment target is 150 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01484730, a study of Abnormal Vascular Flow, is actively recruiting participants, sponsored by University of California, Irvine.

RECRUITING
Registry status
150 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research is to evaluate and validate the performance of non-invasive imaging modalities for assessment of skin. A pressure cuff occlusion will be used to stimulate blood flow dynamic that these instruments are designed to sense. The researcher currently plan to assess only basic feasibility of the imaging instruments.

Primary Outcome

The key factor of interest is measuring the changes in the fluorescence signal of the epidermal cells during the arm occlusion, which will provide information about changes in cellular metabolism during cellular oxygen deprivation. Time series of optical sections (two-dimensional x-y images parallel to the skin surface of about 250x250 µm2) at the same depth will be obtained before, during and after the arm occlusion. The images will be based on two-photon excitation of endogenous fluorophores (

Conditions Studied

Interventions

  • DEVICE Multi-Spectral and Laser Speckle Imaging

Study Locations (1)

California

  • Beckman Laser Institute and Medical Clinic - Irvine

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2011-11
Est. Completion 2028-08
University of California, Irvine

368 total trials

What NCT01484730 shows while recruiting

NCT01484730 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.

The record links to 1 condition, with Abnormal Vascular Flow appearing as the primary indexed condition, and to 1 intervention - of which Multi-Spectral and Laser Speckle Imaging is the first listed.

NCT01484730 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT01484730 about?

NCT01484730 is a clinical study titled "A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion". The purpose of this research is to evaluate and validate the performance of non-invasive imaging modalities for assessment of skin. A pressure cuff occlusion will be used to stimulate blood flow dynamic that these instruments are designed to sense. The researcher currently plan to assess only basic ...

What is the current status of trial NCT01484730?

This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2011-11. Estimated completion is 2028-08.

What conditions does trial NCT01484730 study?

This clinical trial studies the following conditions: Abnormal Vascular Flow.

What interventions are being tested in trial NCT01484730?

The interventions under investigation include: Multi-Spectral and Laser Speckle Imaging (DEVICE).

Who is sponsoring clinical trial NCT01484730?

This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01484730 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

  • NCT02455479 · 150 participants · Phase 1

    Safety Study of a Disrupted Adenovirus (Ad) Serotype Cocaine Vaccine for Cocaine-dependent Individuals

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01484730, the US trial registry maintained by the National Library of Medicine. NCT01484730 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.